Current problems in cardiology · 2026
Predictive performance of the STS-PROM score for acute kidney injury following transfemoral transcatheter aortic valve implantation.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iroulart Juan M, Garmendia Cristian M, Corna Giuliana, Denicolai Martin, Miceli Ana L, Scarponi Camila M, Piñel Sebastián, Seropian Ignacio M, Pizarro Rodolfo, Agatiello Carla R
Аннотация
INTRODUCTION: The Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score is widely used to estimate procedural risk in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). However, its ability to predict acute kidney injury (AKI) after TAVI has not been well established.
OBJECTIVES: To evaluate the predictive performance of the STS-PROM score for post-procedural AKI in patients with symptomatic severe AS undergoing transfemoral TAVI.
METHODS: We conducted a retrospective observational cohort study including consecutive patients with symptomatic severe AS treated with transfemoral TAVI. The primary outcome was AKI after the procedure. The discriminative performance of the STS-PROM score was assessed using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). The optimal cutoff value was determined using the Youden index.
RESULTS: 82 patients were included (mean age, 82.5±6.6 years; 56.8% women). The median STS-PROM score was 4.18 (interquartile range [IQR], 3.22-6.15). AKI occurred in 9 patients (11.0%). The STS-PROM score demonstrated acceptable discriminative performance for predicting AKI (AUC, 0.732; 95% confidence interval [CI], 0.566-0.898; P=0.034). The optimal cutoff value was 5.75, providing 72% sensitivity and 80% specificity. Of the 9 patients who developed AKI, 8 (88.9%) had an STS-PROM score ≥5.75, whereas only 1 (11.1%) had a score <5.75 (P=0.025).
CONCLUSIONS: In patients with symptomatic severe AS undergoing transfemoral TAVI, the STS-PROM score showed acceptable performance for predicting post-procedural AKI. An STS-PROM score ≥5.75 identified patients at increased risk of AKI and may provide additional value for preprocedural risk stratification.
OBJECTIVES: To evaluate the predictive performance of the STS-PROM score for post-procedural AKI in patients with symptomatic severe AS undergoing transfemoral TAVI.
METHODS: We conducted a retrospective observational cohort study including consecutive patients with symptomatic severe AS treated with transfemoral TAVI. The primary outcome was AKI after the procedure. The discriminative performance of the STS-PROM score was assessed using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). The optimal cutoff value was determined using the Youden index.
RESULTS: 82 patients were included (mean age, 82.5±6.6 years; 56.8% women). The median STS-PROM score was 4.18 (interquartile range [IQR], 3.22-6.15). AKI occurred in 9 patients (11.0%). The STS-PROM score demonstrated acceptable discriminative performance for predicting AKI (AUC, 0.732; 95% confidence interval [CI], 0.566-0.898; P=0.034). The optimal cutoff value was 5.75, providing 72% sensitivity and 80% specificity. Of the 9 patients who developed AKI, 8 (88.9%) had an STS-PROM score ≥5.75, whereas only 1 (11.1%) had a score <5.75 (P=0.025).
CONCLUSIONS: In patients with symptomatic severe AS undergoing transfemoral TAVI, the STS-PROM score showed acceptable performance for predicting post-procedural AKI. An STS-PROM score ≥5.75 identified patients at increased risk of AKI and may provide additional value for preprocedural risk stratification.